Histone deacetylase 3-specific inhibitor RGFP966 attenuates oxidative stress and inflammation after traumatic brain injury by activating the Nrf2 pathway

Abstract

Background: Oxidative stress (OS) and inflammatory reactions play pivotal roles in secondary brain injury after traumatic brain injury (TBI). Histone deacetylase 3 (HDAC3) controls the acetylation of histones and non-histones, which has a significant impact on the central nervous system’s reaction to damage. This research determined the implications of RGFP966, a new and specific inhibitor of HDAC3, for the antioxidant (AO) systems mediated by nuclear factor erythroid2-related factor 2 (Nrf2) and the Nod-like receptor protein 3 (NLRP3) inflammasome in TBI. The study also studied the underlying mechanisms of RGFP966’s actions. Our objective was to examine the impacts and underlying RGFP966 mechanisms in TBI. Methods: In vitro, a rat cortical neuron OS model was induced by H₂O₂, followed by the addition of RGFP966 to the culture medium. Neurons were collected after 24 h for western blot (WB), terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and 2′-7′-dichlorodihydrofluorescein diacetate staining. In vivo, RGFP966 (10 mg/kg) was administered post-TBI. Brain tissue water content and modified neurological severity scores were assessed 72 h post-injury. Cortical tissues surrounding the focal injury were subjected to western blot, TUNEL staining, Nissl staining and immunofluorescence/immunohistochemistry staining, and malondialdehyde level, hindered glutathione content and superoxide dismutase activity were measured. Serum was collected for the enzyme-linked immunosorbent assay. Nrf2-specific shRNA lentivirus was injected into the lateral ventricle of rats for 7 days, and cerebral cortex tissue was analyzed by WB and real-time polymerase chain reaction. Results: During in vitro and in vivo experiments, RGFP966 suppressed HDAC3 expression, promoted Nrf2 nuclear translocation, activated downstream AO enzymes, mitigated excessive reactive oxygen species production and alleviated nerve cell apoptosis. RGFP966 effectively reduced brain edema and histological damage and enhanced neurological and cognitive function in rats with TBI. RGFP966 markedly inhibited NLRP3 inflammasome activation mediated by high-mobility group box 1 (HMGB1)/toll-like receptor 4 (TLR4). Nrf2 knockdown in TBI rats attenuated the AO and anti-inflammatory, neuroprotective impacts of RGFP966. Conclusions: Overall, our findings demonstrate that RGFP966 can mitigate the first brain damage and neurological impairments in TBI. The underlying mechanism involves triggering the Nrf2-mediated AO system and negatively regulating the HMGB1/TLR4-mediated NLRP3 inflammasome pathway.

Keywords

TBI / Oxidative stress / Histone deacetylase 3 / NRF2 / Inflammation

References

[1] Cornelius C, Crupi R, Calabrese V, Graziano A, Milone P, Pennisi G, et al. Traumatic brain injury: oxidative stress and neuroprotection[J]. Antioxid Redox Signal. 2013; 19: 836-53.

[2] Simon DW, McGeachy MJ, Bayir H, Clark RS, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury[J]. Nat Rev Neurol. 2017; 13: 171-91.

[3] Khatri N, Thakur M, Pareek V, Kumar S, Sharma S, Datusalia AK. Oxidative stress: major threat in traumatic brain injury[J]. CNS Neurol Disord Drug Targets. 2018; 17: 689-95.

[4] Eastman CL, D’Ambrosio R, Ganesh T. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury[J]. Neuropharmacology. 2020; 172: 107907.

[5] Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory Signaling[J]. Circ Res. 2018; 122: 877-902.

[6] Zhao XJ, Zhu HY, Wang XL, Lu XW, Pan CL, Xu L, et al. Oridonin ameliorates traumatic brain injury-induced neurological damage by improving mitochondrial function and antioxidant capacity and suppressing Neuroinflammation through the Nrf2 pathway[J]. J Neurotrauma. 2022; 39: 530-43.

[7] Wang H, Zhou XM, Wu LY, Liu GJ, Xu WD, Zhang XS, et al. Aucubin alleviates oxidative stress and inflammation via Nrf2-mediated signaling activity in experimental traumatic brain injury[J]. J Neuroinflammation. 2020; 17: 188.

[8] Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang S, et al. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS and/or NF-kappaB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway[J]. J Neuroinflammation. 2017; 14: 119.

[9] van Muiswinkel FL, Kuiperij HB. The Nrf2-ARE signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders[J]. Curr Drug Targets CNS Neurol Disord. 2005; 4: 267-81.

[10] Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine[J]. Clin Chim Acta. 2007; 375: 36-42.

[11] Lei C, Li Y, Zhu X, Li H, Chang X. HMGB1/TLR4 induces autophagy and promotes neuroinflammation after intracerebral hemorrhage[J]. Brain Res. 2022; 1792: 148003.

[12] O’Brien WT, Pham L, Symons GF, Monif M, Shultz SR, McDonald SJ. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target[J]. J Neuroinflammation. 2020; 17: 104.

[13] Bauernfeind F, Bartok E, Rieger A, Franchi L, Núñez G, Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome[J]. J Immunol. 2011; 187: 613-7.

[14] Frank MG, Weber MD, Fonken LK, Hershman SA, Watkins LR, Maier SF. The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome[J]. Brain Behav Immun. 2016; 55: 215-24.

[15] Wang Y, Sedlacek AL, Pawaria S, Xu H, Scott MJ, Binder RJ. Cutting edge: the heat shock protein gp96 activates Inflammasome-Signaling platforms in APCs[J]. J Immunol. 2018; 201: 2209-14.

[16] Ojala JO, Sutinen EM. The role of Interleukin-18, oxidative stress and metabolic syndrome in Alzheimer’s disease[J]. J Clin Med. 2017; 6: 55.

[17] Fiorino E, Giudici M, Ferrari A, Mitro N, Caruso D, De Fabiani E, et al. The sirtuin class of histone deacetylases: regulation and roles in lipid metabolism[J]. IUBMB Life. 2014; 66: 89-99.

[18] D’Mello SR. Histone deacetylase-3: friend and foe of the brain[J]. Exp Biol Med (Maywood). 2020; 245: 1130-41.

[19] Leus NG, Zwinderman MR, Dekker FJ. Histone deacetylase 3 (HDAC 3) as an emerging drug target in NF-kappaB-mediated inflammation[J]. Curr Opin Chem Biol. 2016; 33: 160-8.

[20] Guo X, Hong S, He H, Zeng Y, Chen Y, Mo X, et al. NF-κB promotes oxidative stress-induced necrosis and ischemia/reperfusion injury by inhibiting Nrf2-ARE pathway[J]. Free Radic Biol Med. 2020; 159: 125-35.

[21] Huang S, Chen G, Sun J, Chen Y, Wang N, Dong Y, et al. Histone deacetylase 3 inhibition alleviates type 2 diabetes mellitus-induced endothelial dysfunction via Nrf2[J]. Cell Commun Signal. 2021; 19: 35.

[22] Zhao Q, Zhang F, Yu Z, Guo S, Liu N, Jiang Y, et al. HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice[J]. J Neuroinflammation. 2019; 16: 103.

[23] Malvaez M, McQuown SC, Rogge GA, Astarabadi M, Jacques V, Carreiro S, et al. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner[J]. Proc Natl Acad Sci U S A. 2013; 110: 2647-52.

[24] Bieszczad KM, Bechay K, Rusche JR, Jacques V, Kudugunti S, Miao W, et al. Histone deacetylase inhibition via RGFP966 releases the brakes on sensory cortical plasticity and the specificity of memory formation[J]. J Neurosci. 2015; 35: 13124-32.

[25] Ng SY, Lee A. Traumatic brain injuries: pathophysiology and potential therapeutic targets[J]. Front Cell Neurosci. 2019; 13: 528.

[26] Ganai SA, Ramadoss M, Mahadevan V. Histone deacetylase (HDAC) inhibitors-emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration[J]. Curr Neuropharmacol. 2016; 14: 55-71.

[27] Yang X, Wu Q, Zhang L, Feng L. Inhibition of histone deacetylase 3 (HDAC3) mediates ischemic preconditioning and protects cortical neurons against ischemia in rats[J]. Front Mol Neurosci. 2016; 9: 131.

[28] West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment[J]. J Clin Invest. 2014; 124: 30-9.

[29] Yan W, Pang M, Yu Y, Gou X, Si P, Zhawatibai A, et al. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis[J]. Life Sci. 2019; 231: 116566.

[30] Lu H, Ashiqueali R, Lin CI, Walchale A, Clendaniel V, Matheson R, et al. Histone deacetylase 3 inhibition decreases cerebral Edema and protects the blood-brain barrier after stroke. Mol Neurobiol. 2023; 60: 235-46.

[31] Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X, et al. The ketone metabolite beta-Hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of class I histone deacetylases[J]. J Neurotrauma. 2017; 34: 2645-55.

[32] Yen CH, Hsu CM, Hsiao SY, Hsiao HH. Pathogenic mechanisms of myeloma bone disease and possible roles for NRF2[J]. Int J Mol Sci. 2020; 21: 6723.

[33] Wu AG, Yong YY, Pan YR, Zhang L, Wu JM, Zhang Y., Tang Y, Wei J, Yu L, Law BYK, Yu CL, Liu J, Lan C, Xu RX, Zhou XG, Qin DL Targeting Nrf2-mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals[J]. Oxidative Med Cell Longev, 2022, 2022: 1, 2022, 24.

[34] Sivandzade F, Prasad S, Bhalerao A, Cucullo L. NRF2 and NF-κB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches[J]. Redox Biol. 2019; 21: 101059.

[35] Zhang MJ, Zhao QC, Xia MX, Chen J, Chen YT, Cao X, et al. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome[J]. FASEB J. 2020; 34: 648-62.

[36] Chakraborty R, Tabassum H, Parvez S. NLRP3 inflammasome in traumatic brain injury: its implication in the disease pathophysiology and potential as a therapeutic target[J]. Life Sci. 2023; 314: 121352.

[37] Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019; 20: 3328.

[38] Frank MG, Weber MD, Watkins LR, Maier SF. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming[J]. Brain Behav Immun. 2015; 48: 1-7.